A Clinical Trial of Abciximab in Elective Percutaneous Coronary Intervention after Pretreatment with...
A Clinical Trial of Abciximab in Elective Percutaneous Coronary Intervention after Pretreatment with Clopidogrel
About this item
Full title
Author / Creator
Kastrati, Adnan , Mehilli, Julinda , Schühlen, Helmut , Dirschinger, Josef , Dotzer, Franz , ten Berg, Jurriën M , Neumann, Franz-Josef , Bollwein, Hildegard , Volmer, Christian , Gawaz, Meinrad , Berger, Peter B , Schömig, Albert and Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment Study Investigators
Publisher
Boston, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Boston, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Antiplatelet therapy is used as an adjunct in patients undergoing coronary angioplasty and stenting in order to reduce the incidence of ischemic complications and improve the outcome. In this study of elective coronary stenting, patients were pretreated with aspirin and clopidogrel and then randomly assigned to receive the glycoprotein IIb/IIIa inh...
Alternative Titles
Full title
A Clinical Trial of Abciximab in Elective Percutaneous Coronary Intervention after Pretreatment with Clopidogrel
Authors, Artists and Contributors
Author / Creator
Mehilli, Julinda
Schühlen, Helmut
Dirschinger, Josef
Dotzer, Franz
ten Berg, Jurriën M
Neumann, Franz-Josef
Bollwein, Hildegard
Volmer, Christian
Gawaz, Meinrad
Berger, Peter B
Schömig, Albert
Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment Study Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_223945452
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_223945452
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa031859
